BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahi, J. S
Right arrow Articles by The British Congenital Cataract Interest Group,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahi, J. S
Right arrow Articles by The British Congenital Cataract Interest Group,
Br J Ophthalmol 2001;85:1049-1051 ( September )

Scientific correspondence

Ascertainment of children with congenital cataract through the National Congenital Anomaly System in England and Wales Jugnoo S Rahia, Beverley Bottingb, and The British Congenital Cataract Interest Group*

a Departments of Paediatric Epidemiology and Ophthalmology, Institute of Child Health, Great Ormond Street Hospital NHS Trust, and Department of Epidemiology, Institute of Ophthalmology, London, UK, b Office for National Statistics, London, UK

Correspondence to: Dr J S Rahi, Department of Paediatric Epidemiology and Biostatistics, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK j.rahi{at}ich.ucl.ac.uk

Accepted for publication 27 March 2001

BACKGROUND/AIMS---Congenital ocular anomalies contribute significantly to childhood visual morbidity, with congenital cataract being a major cause of visual impairment throughout the world. As in many other countries, a National Congenital Anomaly System (NCAS) exists in England and Wales to monitor the frequency of ocular and other anomalies in order to identify new public health hazards and inform aetiological research. The aim of this study was to assess level of ascertainment by the NCAS of children with congenital cataract.
METHODS---Using independent ophthalmic and paediatric national active surveillance schemes, all infants (=<1 year) newly diagnosed with congenital and infantile cataract in England and Wales in 1 year from September 1995 were identified. These notifications were compared with those made independently to the NCAS during the same period. The proportion of cases identified by the active surveillance schemes and also notified to the NCAS was determined.
RESULTS---10% (15/149) of eligible children with newly diagnosed congenital or infantile cataract were actually notified to the NCAS. A higher proportion of those diagnosed as neonates (16%, 14/85) than in later infancy (2%, 1/64) was ascertained through the NCAS. There is a need for better verification of notifications and reported information in the NCAS.
CONCLUSION---Currently, ascertainment of congenital cataract through the NCAS is low and the system is likely to be insensitive to small but important changes in risk factors for this disorder. This limits its use for monitoring secular and other trends in ocular anomalies. Strategies to improve its future use are discussed, including enhancing the awareness and participation of ophthalmic professionals involved in managing children with anomalies.


* Members are listed in the appendix.


© 2001 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
M. Chak, J. S. Rahi, and on behalf of the British Congenital Cataract Inter
The health-related quality of life of children with congenital cataract: findings of the British Congenital Cataract Study
Br. J. Ophthalmol., July 1, 2007; 91(7): 922 - 926.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Perveen, J. Favor, R.V. Jamieson, D.W. Ray, and G.C.M. Black
A heterozygous c-Maf transactivation domain mutation causes congenital cataract and enhances target gene activation
Hum. Mol. Genet., May 1, 2007; 16(9): 1030 - 1038.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Chak, A. Wade, J. S. Rahi, and on behalf of the British Congenital Cataract Inter
Long-term visual acuity and its predictors after surgery for congenital cataract: findings of the british congenital cataract study.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4262 - 4269.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd.